Skip to content

    Recently Viewed

      Listening...

      Oncology

      See all stories about oncology, and learn how Johnson & Johnson is advancing the fight to cure and eventually put an end to cancer.
      Health & wellness
      1123 BTN-Lung Cancer-Iede2.jpg
      Health & wellness

      By the numbers: Who gets lung cancer?

      Each year, more people die of lung cancer than colon, breast and prostate cancers combined. Learn how Johnson & Johnson is dedicated to improving outcomes by integrating the company’s MedTech and Innovative Medicine expertise.
      Innovation
      Pipette adding sample to Petri dish for genetic research
      Innovation

      Are super-personalized solutions the future of healthcare?

      The goal of precision medicine is to develop individualized treatments based on a patient’s genetic profile. Here’s how Johnson & Johnson is harnessing this cutting-edge field of tailor-made medicine.
      Personal stories
      no-one-would-believe-me-when-i-suspected-i-had-lung-cancer-0923-new.jpg
      Personal stories

      “No one would believe me when I suspected I had lung cancer”

      Learn about one patient’s journey toward getting an accurate diagnosis—and why it’s crucial to always advocate for your health.
      Personal stories
      so-many-people-were-there-for-me-when-i-had-cancer-now-i-get-to-pay-it-forward-0923-new.jpg
      Personal stories

      “So many people were there for me when I had cancer. Now I get to pay it forward”

      As both a cancer survivor and caregiver, Shauna Smith knows the power of feeling supported when facing the disease. That’s why she founded Johnson & Johnson’s Cancer Focus Group—so every employee has somewhere to turn if they or someone they love is faced with a diagnosis.
      Health & wellness
      Husband and wife sitting on couch looking at laptop
      Health & wellness

      “I’m supporting my husband through cancer treatment”

      When Craig was diagnosed with multiple myeloma, his wife Cara took on a new role: caregiver. Here, she shares the challenges—as well as the triumphs—of this difficult journey.
      Innovation
      5-Things-We-Now-Know-About-Multiple-Myeloma-1122.png
      Innovation

      5 things we now know about multiple myeloma

      Rates of this blood cancer have jumped more than 125% worldwide since the 1990s. But there’s reason to have hope: Today, life expectancy has at least doubled in some cases. That’s thanks to increased research, new learnings and innovative advances—and Johnson & Johnson is at the forefront of this crucial work.
      Innovation
      Noémie-Manuelle Dorval Courchesne, Ph.D., in the lab
      Innovation

      These 6 women in STEM are on a mission to change the world

      The Johnson & Johnson WiSTEM2D Scholars Award Program winners have big ideas—and an even bigger drive to inspire other women studying science, technology, engineering, math, manufacturing and design to pursue their dreams, too.
      Innovation
      Headshots of Dr. Kallenbach, Dr. Madduri and Dr. Cortoos
      Innovation

      Could these 3 researchers transform the fates of patients with multiple myeloma?

      For National Cancer Prevention Month, we’re spotlighting three leading Johnson & Johnson female hematologists—innovators who are not only saving lives and advancing new treatments but also paving the way for the next generation of women in their field.
      Innovation
      How-Data-Science-is-Ushering-in-a-New-Era-of-Modern-Medicine-lede-0422.jpg
      Innovation

      How data science is ushering in a new era of modern medicine

      Algorithms, artificial intelligence, machine learning and other technologies are transforming the way physicians identify, treat and manage diseases. Here’s how Johnson & Johnson is putting the latest tools to work.
      Innovation
      An illustration of microbiomes
      Innovation

      Could changes in your microbiome increase your risk of colorectal cancer?

      That’s exactly what researchers at Johnson & Johnson are trying to find out. By partnering on a new study that’s looking at the role gut microbes may play in the disease—and focusing on the underrepresented groups most affected—they hope to advance early-detection strategies and potential treatments.